Welltower (WELL)
(Delayed Data from NYSE)
$94.00 USD
+0.30 (0.32%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $93.97 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Welltower (WELL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$102.31 | $129.00 | $85.00 | 9.19% |
Price Target
Based on short-term price targets offered by 16 analysts, the average price target for Welltower comes to $102.31. The forecasts range from a low of $85.00 to a high of $129.00. The average price target represents an increase of 9.19% from the last closing price of $93.70.
Analyst Price Targets (16)
Broker Rating
Welltower currently has an average brokerage recommendation (ABR) of 1.74 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.74 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.82% and 5.88% of all recommendations. A month ago, Strong Buy made up 58.82%, while Buy represented 5.88%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.74 | 1.74 | 1.74 | 1.81 | 1.81 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/18/2024 | Exane BNP Paribas | Research Department | Not Available | Strong Buy |
3/4/2024 | Scotiabank | Nicholas Yulico | Strong Buy | Strong Buy |
2/14/2024 | Not Identified | Not Identified | Hold | Hold |
1/3/2024 | Mizuho SecuritiesUSA | Vikram Malhotra | Strong Buy | Strong Buy |
11/9/2023 | Raymond James | Jonathan Hughes | Moderate Buy | Strong Buy |
10/21/2023 | KeyBanc Capital Markets | Austin Wurschmidt | Strong Buy | Strong Buy |
10/3/2023 | Wedbush Securities | Richard Anderson | Hold | Hold |
9/14/2023 | Robert W. Baird & Co. | Wesley Golladay | Not Available | Hold |
7/14/2023 | Evercore Partners | Stephen Sakwa | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.74 |
ABR (Last week) | 1.74 |
# of Recs in ABR | 17 |
Average Target Price | $102.31 |
LT Growth Rate | 9.80% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 147 of 252 |
Current Quarter EPS Est: | 0.94 |